Several clinical and molecular features are used to distinguish these 2 types of MCL, including involvement of lymph nodes, expression of SOX11 (2, 5), and somatic hypermutation on the B cell receptor (BCR) immunoglobulin heavy variable (IGHV) genes (1, 5, 8, 9). The gene discussed is SOX11; the disease is mantle cell lymphoma.